The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trembleau, S.
Right arrow Articles by Adorini, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trembleau, S.
Right arrow Articles by Adorini, L.
The Journal of Immunology, 2001, 167: 4104-4114.
Copyright © 2001 by The American Association of Immunologists

IL-12 Administration Reveals Diabetogenic T Cells in Genetically Resistant I-E{alpha}-Transgenic Nonobese Diabetic Mice: Resistance to Autoimmune Diabetes Is Associated with Binding of E{alpha}-Derived Peptides to the I-Ag7 Molecule1

Sylvie Trembleau*, Silvia Gregori*, Giuseppe Penna*, Irmina Gorny{dagger} and Luciano Adorini2,*

* Roche Milan Ricerche, Milan, Italy; and {dagger} Research Institute of Molecular Pathology, Vienna, Austria

Nonobese diabetic (NOD) and NOD-DR{alpha} transgenic (tg) mice, expressing A{alpha}d:A{beta}g7 and A{alpha}d:A{beta}g7 plus DR{alpha}:E{beta}g7 class II molecules, respectively, both develop insulin-dependent diabetes mellitus (IDDM), whereas NOD-E{alpha} tg mice expressing A{alpha}d:A{beta}g7 plus E{alpha}:E{beta}g7 are protected. We show that IL-12 administration induces rapid IDDM onset in NOD-DR{alpha} but fails to provoke insulitis and diabetes in NOD-E{alpha} tg mice. Nevertheless, T cells from IL-12-treated NOD-E{alpha} tg mice secrete IFN-{gamma} and transfer IDDM to NOD-SCID and NOD-E{alpha}-SCID recipients, demonstrating the presence of peripheral diabetogenic Th1 cells in the protected mice. Surprisingly, regulatory cells were undetectable. Moreover, E{alpha}:E{beta}g7 could substitute for DR{alpha}:E{beta}g7 in Ag presentation, arguing against mechanisms of protection involving capture of diabetogenic I-Ag7-restricted epitopes by E{alpha}:E{beta}g7molecules. Interestingly, the expression of naturally processed epitopes derived from DR{alpha}- and E{alpha}-chains bound to I-Ag7 is different in the two strains of tg mice, and the difference is enhanced by IL-12 administration. I-Ag7 molecules from both NOD-DR{alpha} and NOD-E{alpha} tg mice present the conserved DR{alpha}/E{alpha} 52-68 sequence, at high and low levels, respectively. In addition, only IDDM-resistant NOD-E{alpha} tg mice possess APCs bearing E{alpha}65-77/I-Ag7 complexes, which tolerize the specific T cells. This is associated with the selective inhibition of the response to insulinoma-associated protein 2 (IA-2), an autoantigen in IDDM. Our results support protective mechanisms based on I-Ag7 blockade by peptides unique to the E{alpha}-chain, such as E{alpha}65-77 and/or tolerance of diabetogenic T cells cross-reactive with E{alpha}-peptide/I-Ag7 complexes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
N. K. Brown, D. J. McCormick, C. S. David, and Y.-c. M. Kong
H2E-Derived E{alpha}52-68 Peptide Presented by H2Ab Interferes with Clonal Deletion of Autoreactive T Cells in Autoimmune Thyroiditis
J. Immunol., May 15, 2008; 180(10): 7039 - 7046.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, N. Giarratana, and L. Adorini
IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-{gamma}-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-{gamma}
J. Immunol., June 1, 2003; 170(11): 5491 - 5501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.